Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
NYR-BI03
Myocardial Ischemia
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
30-Apr-2024
Nyrada Commences Walter Reed Traumatic Brain Injury Study
18-Apr-2024
Investor Presentation - April 2024
11-Apr-2024
3QFY2024 Results and Investor Conference Call
10-Apr-2024
Quarterly Activities Report and Appendix 4C
2-Apr-2024
2024 EGM Letter to Shareholders and Proxy
2-Apr-2024
2024 EGM Notice of Meeting and Proxy
28-Mar-2024
Nyrada Commences Key Brain Injury Program Preclinical Study
15-Mar-2024
Notice of Change of Interests of Substantial Securityholder
15-Mar-2024
Notice of Change of Interests of Substantial Securityholder
15-Mar-2024
Cleansing Statement
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
Next
